MIM
EXAS

MetLife Investment Management’s Exact Sciences EXAS Stock Holding History

MetLife Investment Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,543
Closed -$360K – 2794
2025
Q4 		$360K Sell
3,543
-49
-1% -$3.94K ﹤0.01% 1951
2025
Q3 		$197K Buy
3,592
+23
+0.6% +$1.15K ﹤0.01% 2325
2025
Q2 		$190K Sell
3,569
-2,846
-44% -$145K ﹤0.01% 2228
2025
Q1 		$278K Buy
6,415
+35
+0.5% +$1.77K ﹤0.01% 2018
2024
Q4 		$358K Sell
6,380
-95
-1% -$5.91K ﹤0.01% 1979
2024
Q3 		$441K Sell
6,475
-133
-2% -$7.51K ﹤0.01% 1847
2024
Q2 		$279K Buy
6,608
+566
+9% +$31.1K ﹤0.01% 2042
2024
Q1 		$417K Buy
6,042
+17
+0.3% +$1.07K ﹤0.01% 1779
2023
Q4 		$446K Sell
6,025
-95
-2% -$6.23K ﹤0.01% 1757
2023
Q3 		$418K Buy
6,120
+5
+0.1% +$424 ﹤0.01% 1743
2023
Q2 		$574K Buy
6,115
+1,233
+25% +$96.2K ﹤0.01% 1602
2023
Q1 		$331K Buy
4,882
+11
+0.2% +$707 ﹤0.01% 1898
2022
Q4 		$241K Sell
4,871
-36
-0.7% -$1.47K ﹤0.01% 2131
2022
Q3 		$159K Sell
4,907
-70
-1% -$2.89K ﹤0.01% 2434
2022
Q2 		$196K Sell
4,977
-5,629
-53% -$301K ﹤0.01% 2331
2022
Q1 		$742K Buy
+10,606
New +$775K ﹤0.01% 1523
2019
Q2 		– Sell
-164
Closed -$14.2K – 2484
2019
Q1 		$14.2K Buy
164
+1
+0.6% +$85 ﹤0.01% 2360
2018
Q4 		$10.3K Sell
163
-2
-1% -$137 ﹤0.01% 2373
2018
Q3 		$13K Buy
+165
New +$10.8K ﹤0.01% 2413
2018
Q2 		– Sell
-52,309
Closed -$2.11M – 2186
2018
Q1 		$2.11M Sell
52,309
-2,023
-4% -$98.7K 0.02% 763
2017
Q4 		$2.85M Buy
+54,332
New +$2.9M 0.03% 663

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

MetLife Investment Management's EXAS Position: Q1 2026 in Review

MetLife Investment Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,543 shares — an estimated $360K sold.

MetLife Investment Management first reported a position in EXAS in Q4 2017 and held it in 21 quarters. The position peaked at $2.85M in Q4 2017. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • MetLife Investment Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • MetLife Investment Management sold 3,543 Exact Sciences shares in Q1 2026, an estimated $360K.
  • MetLife Investment Management first reported a position in Exact Sciences in Q4 2017 and held it in 21 quarters.
  • MetLife Investment Management's Exact Sciences position peaked at $2.85M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.